Chunkang Chang

2.4k total citations
127 papers, 1.6k citations indexed

About

Chunkang Chang is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Chunkang Chang has authored 127 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Hematology, 43 papers in Molecular Biology and 39 papers in Genetics. Recurrent topics in Chunkang Chang's work include Acute Myeloid Leukemia Research (87 papers), Hematopoietic Stem Cell Transplantation (17 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers). Chunkang Chang is often cited by papers focused on Acute Myeloid Leukemia Research (87 papers), Hematopoietic Stem Cell Transplantation (17 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers). Chunkang Chang collaborates with scholars based in China, United States and Japan. Chunkang Chang's co-authors include Juan Guo, Lingyun Wu, Youshan Zhao, Qi He, Zheng Zhang, Chengming Fei, Dong Wu, Sida Zhao, Feng Xu and Jiying Su and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Chunkang Chang

113 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunkang Chang China 21 975 696 415 224 206 127 1.6k
Pinkal Desai United States 17 679 0.7× 398 0.6× 308 0.7× 198 0.9× 371 1.8× 71 1.2k
Mohammad Shahjahani Iran 19 463 0.5× 580 0.8× 350 0.8× 247 1.1× 267 1.3× 67 1.3k
Haruko Shima Japan 13 593 0.6× 505 0.7× 266 0.6× 190 0.8× 307 1.5× 34 1.2k
Monika Jansson Sweden 21 461 0.5× 683 1.0× 530 1.3× 133 0.6× 144 0.7× 41 1.5k
Angelo Guerrasio Italy 24 938 1.0× 787 1.1× 547 1.3× 255 1.1× 128 0.6× 105 1.7k
Rajko Kušec Croatia 24 1.0k 1.0× 979 1.4× 887 2.1× 280 1.3× 190 0.9× 104 2.0k
Carmelo Gurnari Italy 19 592 0.6× 364 0.5× 324 0.8× 151 0.7× 82 0.4× 141 1.0k
Jacqueline Vuong United States 8 485 0.5× 413 0.6× 331 0.8× 104 0.5× 128 0.6× 12 1.2k
Savchenko Vg Russia 14 506 0.5× 317 0.5× 399 1.0× 301 1.3× 55 0.3× 281 1.2k
Juan Guo China 16 495 0.5× 388 0.6× 257 0.6× 150 0.7× 120 0.6× 68 858

Countries citing papers authored by Chunkang Chang

Since Specialization
Citations

This map shows the geographic impact of Chunkang Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunkang Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunkang Chang more than expected).

Fields of papers citing papers by Chunkang Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunkang Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunkang Chang. The network helps show where Chunkang Chang may publish in the future.

Co-authorship network of co-authors of Chunkang Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chunkang Chang. A scholar is included among the top collaborators of Chunkang Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunkang Chang. Chunkang Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Chunkang, Takahiro Suzuki, Yang Liang, et al.. (2025). Safety and efficacy of luspatercept in treating anemia associated with myelodysplastic syndrome with ring sideroblasts in Asian patients who require red blood cell transfusions: a phase II bridging study. Therapeutic Advances in Hematology. 16. 1584239475–1584239475. 1 indexed citations
2.
Chang, Chunkang, Min Zhang, Sujun Gao, et al.. (2024). Rovadicitinib in Patients with Myelofibrosis Who Were Refractory or Relapsed or Intolerant to Ruxolitinib: A Single Arm, Multicenter, Open-Label, Phase Ib Study. Blood. 144(Supplement 1). 484–484. 1 indexed citations
3.
Wang, Huafeng, Xudong Wei, Yang Liang, et al.. (2024). Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor, in Combination with Azacitidine in Treatment of Patients with Myelodysplastic Syndrome (MDS). Blood. 144(Supplement 1). 3202–3202.
4.
Wang, Huafeng, Xudong Wei, Qian Jiang, et al.. (2024). Safety and efficacy of lisaftoclax, a novel BCL-2 inhibitor, in combination with azacitidine in patients with treatment-naïve or relapsed or refractory acute myeloid leukemia.. Journal of Clinical Oncology. 42(16_suppl). 6541–6541. 1 indexed citations
5.
Yang, Wei, Sujun Gao, Xiaojing Yan, et al.. (2024). Latest results of a phase 2 study of IMM01 combined with azacitidine (AZA) as the first-line treatment in adults with higher risk myelodysplastic syndromes (MDS).. Journal of Clinical Oncology. 42(16_suppl). 6510–6510.
6.
7.
Zhang, Yao, Yan Qian, Luxi Song, Chao Xiao, & Chunkang Chang. (2022). The use of carbon monoxide breath test to detect the effect of iron overload on erythrocyte lifespan in MDS. Frontiers in Oncology. 12. 1058482–1058482. 4 indexed citations
8.
Zhang, Zheng, et al.. (2022). Decreased FOXO1 Expression Is Correlated with Poor Prognosis in Myelodysplastic Syndromes. Current Oncology. 29(10). 6933–6946.
9.
Fang, Ying, Juan Guo, Dong Wu, et al.. (2021). Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome. Frontiers in Oncology. 10. 610525–610525. 4 indexed citations
10.
Li, Xiao, Feng Xu, Zheng Zhang, et al.. (2021). Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome. Clinical Epigenetics. 13(1). 169–169. 4 indexed citations
11.
12.
13.
Zhao, Sida, Youshan Zhao, Juan Guo, et al.. (2017). Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation. Scientific Reports. 7(1). 43849–43849. 13 indexed citations
14.
Song, Luxi, Juan Guo, Qi He, et al.. (2012). Bone Marrow Mesenchymal Stem Cells in Myelodysplastic Syndromes: Cytogenetic Characterization. Acta Haematologica. 128(3). 170–177. 4 indexed citations
15.
Zhao, Youshan, Chengming Fei, Xi Zhang, et al.. (2012). Methylation of the p73 gene in patients with myelodysplastic syndromes: correlations with apoptosis and prognosis. Tumor Biology. 34(1). 165–172. 9 indexed citations
16.
17.
Yang, Rui, Jie Pu, Juan Guo, et al.. (2011). The biological behavior of SDF-1/CXCR4 in patients with myelodysplastic syndrome. Medical Oncology. 29(2). 1202–1208. 6 indexed citations
18.
Xu, Feng, Xiao Li, Lingyun Wu, et al.. (2010). Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS‐based immunophenotypes. British Journal of Haematology. 149(4). 587–597. 20 indexed citations
19.
20.
Li, Xiao, Yizhi Liu, Ying Tao, et al.. (2003). [Relationship between macrophages and apoptosis in patients with myelodysplastic syndromes].. PubMed. 32(3). 226–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pinkal Desai Breakdown of academic impact, for papers by Mohammad Shahjahani Breakdown of academic impact, for papers by Haruko Shima Breakdown of academic impact, for papers by Monika Jansson Breakdown of academic impact, for papers by Angelo Guerrasio Breakdown of academic impact, for papers by Rajko Kušec Breakdown of academic impact, for papers by Carmelo Gurnari Breakdown of academic impact, for papers by Jacqueline Vuong Breakdown of academic impact, for papers by Savchenko Vg Breakdown of academic impact, for papers by Juan Guo
Rankless by CCL
2026